The significance of serum anti-Müllerian hormone (AMH) levels in patients over age 40 in first IVF treatment

Journal of Assisted Reproduction and Genetics

Volumn 30, Issue 6, 2013, Pages 821-825

  Tokura, Yoko ^c   Yoshino, Osamu ^a,b,c   Ogura Nose, Sayaka ^a   Motoyama, Hiroshi ^d   Harada, Miyuki ^a   Osuga, Yutaka ^a   Shimizu, Yasushi ^d   Ohara, Motohiro ^d   Yorimitsu, Takeshi ^d   Nishii, Osamu ^c   Kozuma, Shiro ^a   Kawamura, Toshihiro ^d  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOYAMA   (Japan)

^c TEIKYO UNIVERSITY   (Japan)

^d Denentoshi Ladies Clinic   (Japan)

Author keywords

Aged; AMH; Infertility; IVF

Indexed keywords

CLOMIFENE CITRATE; HUMAN MENOPAUSAL GONADOTROPIN; MUELLERIAN INHIBITING FACTOR;

ADULT; ARTICLE; BLOOD SAMPLING; CELL COUNT; CLINICAL ARTICLE; EMBRYO TRANSFER; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; GROUPS BY AGE; HUMAN; OOCYTE RETRIEVAL; OVARY FOLLICLE CELL; PREDICTION; PREGNANCY; PREGNANCY RATE; PREGNANT WOMAN; PRIORITY JOURNAL;

ADULT; AGE FACTORS; ANTI-MULLERIAN HORMONE; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; HUMANS; INFERTILITY, FEMALE; OOCYTE RETRIEVAL; OOCYTES; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE;

EID: 84879840694     PISSN: 10580468     EISSN: 15737330     Source Type: Journal    
DOI: 10.1007/s10815-013-9991-3     Document Type: Article

References (14)

1. Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Updat. 2006;12(6):685-718.
2. Broer SL, Mol BWJ, Hendriks D, Broekmans FJM. Role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count. Fertil Steril. 2009;91(3):705-14.
3. Ferraretti AP et al. ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria. Human Reprod (Oxford, England). 2011;26(7):1616-24.
4. Fujimoto A et al. Predictive factors of successful pregnancy after assisted reproductive technology in women aged 40 years and older. Reprod Med Biol. 2009;8(4):145-9.
5. Khader A et al. External validation of anti-Müllerian hormone based prediction of live birth in assisted conception. J Ovarian Res. 2013;6(1):3.
6. Leridon H. Demographic effects of the introduction of steroid contraception in developed countries. Hum Reprod Updat. 2006;12(5):603-16.
7. Lie Fong S et al. Anti-Müllerian hormone: a marker for oocyte quantity, oocyte quality and embryo quality? Reprod Biomed Online. 2008;16(5):664-70.
8. La Marca A et al. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Updat. 2010;16(2):113-30.
9. La Marca A, Stabile G, Carducci Artenisio A, Volpe A. Serum anti-Mullerian hormone throughout the human menstrual cycle. Human Reprod (Oxford, England). 2006;21(12):3103-7.
10. Van Rooij IAJ et al. Serum anti-Müllerian hormone levels: a novel measure of ovarian reserve. Human Reprod (Oxford, England). 2002;17(12):3065-71.
11. Spandorfer SD et al. An analysis of the effect of age on implantation rates. J Assist Reprod Genet. 2000;17(6):303-6.
12. Spira A. The decline of fecundity with age. Maturitas Suppl. 1988;1:15-22.
13. Weenen C et al. Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod. 2004;10(2):77-83.
14. Weghofer A, Dietrich W, Barad DH, Gleicher N. Live birth chances in women with extremely low-serum anti-Mullerian hormone levels. Human Reprod (Oxford, England). 2011;26(7):1905-9.